⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 21, 2024Open Access

Homozygous FANCM variant c.5101C>T p.(Gln1701*) in a patient with early onset breast cancer, chemotherapy toxicity, and chromosome fragility

Sonja Sulkava Anna H. Hakonen Minna Pöyhönen Heli Nevanlinna

View Full Paper

Ask AI

Bookmark

Share

Abstract

BackgroundBiallelic FANCM variants are linked to a Fanconi anemia-like cancer predisposition syndrome which includes early onset breast cancer, chemotherapy toxicity and chromosome fragility.Additionally, heterozygous

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sulkava et al. (2024) studied this question.

synapsesocial.com/papers/68e63c23b6db6435875ce758 https://doi.org/10.22541/au.171898795.53158005/v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Homozygous <i>FANCM</i> Variant c.5101C>T p.(Gln1701*) in a Patient With Early Onset Breast Cancer, Chemotherapy Toxicity, and Chromosome Fragility: A Case Report2025
2Recessive FANCM cancer syndrome with high cancer risks, chemotherapy toxicity, chromosome fragility, and gonadal failureOriginal Research · 2025 · 2 citations
3Biallelic <i>FANCA</i> variants detected in sisters with isolated premature ovarian insufficiency2024 · 4 citations
4Predisposition to ALL and Solid Tumors Rather Than Bone Marrow Failure in <i>FANCM</i> -Associated Fanconi AnemiaOriginal Research · 2026 · 3 citations
5Fanconi Anemia Complementation Group C Gene (FANCC) Association with Hereditary and Sporadic Renal TumorsOriginal Research · 2026 · 1 citations